Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
Clinical trial NCT05653453 · RECRUITING
Trial details
- NCT number
- NCT05653453
- Sponsor
- Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2026-12-25
- Enrollment
- 512
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.